Question 1

What is the life expectancy of someone with Eales Disease?

Accepted Answer

Eales Disease is an idiopathic retinal vasculitis that generally does not reduce life expectancy, as it primarily affects the blood vessels of the eye rather than systemic organ function. While the condition can lead to significant vision impairment or blindness if left untreated, the overall prognosis for longevity remains excellent when managed by a specialized ophthalmologist.

What is the long-term prognosis for Eales Disease?
The clinical course of Eales Disease is highly variable, often characterized by periods of inflammation followed by quiescence. Because Eales Disease is typically confined to the peripheral retina, it does not carry the mortality risks associated with systemic vasculitis. Most individuals diagnosed with Eales Disease lead full, normal lifespans, though the quality of life can be significantly impacted by the risk of recurrent vitreous hemorrhage and retinal detachment.

How do treatments influence outcomes in Eales Disease?
Advances in medical technology have dramatically improved the management of Eales Disease over the last few decades. Early intervention is critical to preventing permanent vision loss. Modern therapeutic approaches often involve:

Corticosteroids: Used to manage acute inflammatory phases.
    Laser Photocoagulation: Highly effective in treating peripheral retinal ischemia.
    Pars Plana Vitrectomy: A surgical procedure utilized to clear persistent vitreous hemorrhage.
    Anti-VEGF therapy: Increasingly used to manage neovascularization associated with Eales Disease.

Why is regular follow-up essential for Eales Disease?
Because Eales Disease can be asymptomatic in its early stages, regular screenings are vital. Consistent monitoring by a retina specialist allows for the detection of subtle changes before they progress to severe complications. At DiseaseMaps.org, 23 people with Eales Disease have shared their experiences, highlighting that proactive, long-term ophthalmic care is the most effective strategy for preserving vision and maintaining a high quality of life.

Next steps

Schedule a comprehensive dilated eye exam with a retina specialist.
    Join the DiseaseMaps.org community to connect with others who have Eales Disease.
    Maintain a log of any visual changes, such as floaters or blurred vision, to discuss during your next appointment.
    Consult with a rheumatologist if your physician suspects any underlying systemic associations.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

NIH Genetic and Rare Diseases Information Center (GARD): Eales Disease profile.
    Orphanet: Rare disease database entry for retinal vasculitis.
    PubMed: Longitudinal clinical studies on peripheral retinal vasculitis outcomes.
    American Academy of Ophthalmology (AAO) clinical guidelines for peripheral retinal disorders.

Question 2

Celebrities with Eales Disease

Accepted Answer

There are currently no globally recognized celebrities or high-profile public figures who have publicly disclosed a diagnosis of Eales disease. Because Eales disease is a rare, idiopathic inflammatory condition primarily affecting the peripheral retina, awareness is driven by medical researchers and patient-led advocacy rather than celebrity influence.

Why is there limited public awareness of Eales disease?
Eales disease is a rare retinal vasculopathy that predominantly affects young, healthy males, mostly in the Indian subcontinent. Due to its status as a rare disease, it lacks the broad media visibility often associated with more common chronic conditions. While there are no famous faces associated with Eales disease, the lack of celebrity advocacy has not hindered the dedicated efforts of ophthalmologists and specialized research groups who continue to study its underlying causes, such as the potential link to Mycobacterium tuberculosis exposure.

Who are the key figures championing Eales disease research?
Advocacy for Eales disease is primarily led by the medical community and patient-support networks. Rather than celebrity campaigns, awareness relies on:

Ophthalmology research centers, such as the Aravind Eye Care System, which have published extensive clinical data on the condition.
    Medical journals that provide platforms for researchers to share findings on treatments like laser photocoagulation and immunosuppressive therapy.
    Community-driven platforms like DiseaseMaps.org, where 23 individuals currently connect to share their lived experiences with Eales disease.

How does community advocacy impact Eales disease progress?
The 23 members of the DiseaseMaps.org community provide a vital grassroots voice for those living with Eales disease. By sharing personal data and symptom management strategies, these patients help bridge the gap between clinical research and daily reality. This collective action is essential for increasing the visibility of Eales disease among healthcare providers, ensuring that patients receive earlier diagnoses and more compassionate, informed care.

Next steps

Consult a retina specialist or ophthalmologist if you experience floaters, blurred vision, or sudden visual field loss.
    Join the Eales disease community at DiseaseMaps.org to connect with others who understand your journey.
    Stay informed by reviewing the latest clinical literature on PubMed regarding advancements in retinal inflammation management.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD)
    Orphanet: Portal for rare diseases and orphan drugs
    PubMed: Current clinical research on idiopathic retinal vasculitis
    DiseaseMaps.org: Community-based rare disease data

Question 3

Is Eales Disease hereditary?

Accepted Answer

Eales disease is currently not considered an inherited or hereditary condition, as there is no evidence that it follows Mendelian patterns of inheritance. Instead, Eales disease is widely regarded as an idiopathic inflammatory condition, likely involving a complex interplay between environmental factors, immune system dysregulation, and potentially infectious triggers like Mycobacterium tuberculosis.

Is Eales disease a genetic disorder?
Current clinical research does not classify Eales disease as a genetic or hereditary disorder. While researchers have investigated potential human leukocyte antigen (HLA) associations that might predispose certain individuals to the condition, these are considered susceptibility markers rather than causative genetic mutations. Unlike strictly genetic diseases, Eales disease does not result from a single gene mutation passed from parents to children.

What is the role of genetic counseling for Eales disease?
Because Eales disease is not hereditary, traditional genetic counseling to determine recurrence risk for children is generally not indicated. However, patients may seek consultations with medical geneticists if they are concerned about a family history of autoimmune or inflammatory eye conditions that might mimic the clinical presentation of Eales disease. Understanding that this is not a Mendelian condition can provide significant relief to families worried about passing the disease to future generations.

What factors contribute to the development of Eales disease?
While the exact etiology remains elusive, clinical data suggests that Eales disease is multifactorial. Key observations include:

Immune Response: Hypersensitivity to tubercular proteins is a major suspected trigger.
    Environmental Triggers: Exposure to certain pathogens may initiate the inflammation of the retinal blood vessels.
    Demographics: It primarily affects young, healthy males, usually between the ages of 20 and 40.
    Autoimmunity: Systemic inflammation and vasculitis are central to the pathology of Eales disease.

Next steps

Consult an ophthalmologist specializing in uveitis or retinal vascular diseases for regular screenings.
    Join our community of 23 members at DiseaseMaps.org to share experiences and coping strategies.
    Monitor systemic health for signs of underlying inflammatory or infectious conditions.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

NIH Genetic and Rare Diseases Information Center (GARD) - Eales Disease overview.
    Orphanet: Portal for rare diseases and orphan drugs.
    PubMed/NCBI: Current clinical literature on idiopathic retinal vasculitis.

Question 4

Is Eales Disease contagious?

Accepted Answer

Eales Disease is not contagious and cannot be spread from person to person through touch, proximity, or daily interaction. It is an idiopathic inflammatory condition primarily affecting the peripheral retina, and there is no risk of transmission to family members, caregivers, or friends.

What is the underlying cause of Eales Disease?
The exact cause of Eales Disease remains unknown, though it is widely classified as an idiopathic inflammatory retinal vasculopathy. Research suggests that Eales Disease may involve an immune-mediated response, potentially triggered by an underlying hypersensitivity to specific antigens, such as Mycobacterium tuberculosis proteins, even in patients without active systemic tuberculosis. It is not considered a genetic or hereditary condition, and it typically presents in healthy young adults, most commonly males between the ages of 20 and 40.

Why is there confusion regarding the contagiousness of Eales Disease?
The misconception that Eales Disease is contagious often stems from its historical association with tuberculosis. Because some clinical studies have identified a link between ocular inflammation in Eales Disease and exposure to tuberculosis, patients are sometimes incorrectly labeled as "infectious." However, Eales Disease is an inflammatory reaction, not an active infection. You cannot "catch" Eales Disease from someone else, nor can you pass it on through any form of physical contact.

What factors are associated with Eales Disease?
While Eales Disease is not an infectious disease, clinical observations have identified several factors often present in those diagnosed:

Demographics: It primarily affects young, healthy males, with a male-to-female ratio of approximately 9:1.
    Immune Response: There is often a documented history of exposure to tuberculosis, leading to a localized hypersensitivity reaction in the eye.
    Inflammation: The condition is characterized by peripheral periphlebitis (inflammation of the retinal veins), which can lead to retinal hemorrhages and neovascularization.
    Geography: It was first described in India and remains more frequently reported in South Asia, though it occurs globally.

Next steps

Schedule regular follow-ups with a retina specialist or ophthalmologist to monitor retinal health.
    Connect with the 23 members of the Eales Disease community on DiseaseMaps.org to share experiences and reduce isolation.
    Consult your physician about screening for systemic inflammatory markers or latent tuberculosis if recommended by your specialist.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

NIH Genetic and Rare Diseases Information Center (GARD)
    Orphanet: Portal for rare diseases and orphan drugs
    PubMed: Clinical reviews on idiopathic retinal vasculitis
    American Academy of Ophthalmology (AAO) EyeWiki

Question 5

ICD10 code of Eales Disease and ICD9 code

Accepted Answer

Eales disease is classified under the ICD-10 code H35.09 (Other intraretinal microvascular abnormalities) and the ICD-9 code 362.18 (Retinal vasculitis). Because it is a rare idiopathic retinal vasculitis, it does not have a unique, disease-specific diagnostic code in either system, necessitating the use of these broader ophthalmological classifications.

What is the clinical nature of Eales disease?
Eales disease is a rare, idiopathic inflammatory condition primarily affecting the peripheral retina. It is characterized by three distinct stages: periphlebitis, capillary non-perfusion, and neovascularization. Patients with Eales disease often present with symptoms like floaters, blurred vision, or sudden vision loss due to vitreous hemorrhage. Within the DiseaseMaps community, 23 people have shared their experiences with Eales disease, highlighting the emotional toll of navigating a condition that often lacks a single, definitive diagnostic code.

How is Eales disease diagnosed and classified?
Diagnosis of Eales disease is typically one of exclusion, meaning other systemic inflammatory or infectious diseases must be ruled out first. Since there is no specific ICD code for Eales disease, clinicians rely on clinical presentation and imaging to track the progression of the condition. Key clinical features include:

Peripheral retinal periphlebitis (inflammation of the retinal veins)
    Peripheral retinal ischemia (lack of blood flow)
    Neovascularization of the retina or optic disc
    Recurrent vitreous hemorrhages

Is there a known cause for Eales disease?
The exact etiology of Eales disease remains unknown, though it is strongly associated with a hypersensitivity reaction to tuberculoproteins. While Eales disease is not strictly considered hereditary, the underlying immunological triggers are a subject of ongoing research. Because Eales disease primarily affects young, healthy males, it is essential to monitor for systemic health markers during the diagnostic process.

Next steps

Consult a retina specialist or uveitis expert for a comprehensive dilated fundus examination.
    Undergo fluorescein angiography to map the extent of retinal vascular involvement in Eales disease.
    Join the 23-member strong community at DiseaseMaps.org to share experiences and coping strategies with others living with Eales disease.

Medical disclaimer: This content is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the guidance of your physician regarding a medical condition.

References

National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD)
    Orphanet: Portal for rare diseases and orphan drugs
    PubMed: Clinical reviews on idiopathic retinal vasculitis
    International Classification of Diseases (ICD-10/ICD-9) coding manuals

Question 6

Is there any natural treatment for Eales Disease?

Accepted Answer

There is currently no scientifically validated "natural" cure for Eales disease, an idiopathic inflammatory condition characterized by peripheral retinal vasculitis. While complementary therapies may support overall well-being, they cannot replace standard medical interventions like corticosteroids, laser photocoagulation, or anti-VEGF injections required to prevent vision loss.

Are there evidence-based natural treatments for Eales disease?
To date, no clinical trials support the use of herbal remedies, supplements, or specific diets as curative treatments for Eales disease. Because the exact etiology of Eales disease remains uncertain—though it is strongly associated with a hypersensitivity reaction to Mycobacterium tuberculosis—management must focus on controlling inflammation under the direct supervision of an ophthalmologist.

What complementary approaches do patients commonly explore?
Many patients in the DiseaseMaps community, which currently includes 23 individuals living with Eales disease, often inquire about anti-inflammatory lifestyle modifications. While evidence is largely anecdotal, some patients report that the following practices help manage the stress associated with chronic vision concerns:

Mind-body practices: Yoga and mindfulness meditation may help reduce the psychological burden of living with a rare, sight-threatening condition.
    Anti-inflammatory nutrition: Diets rich in Omega-3 fatty acids and antioxidants are generally encouraged for systemic health, though they do not treat the retinal vasculitis inherent in Eales disease.
    Acupuncture: While sometimes used for ocular symptom management, there is no clinical evidence that it alters the progression of Eales disease.

What are the risks of alternative therapies?
The primary risk of relying on alternative therapies for Eales disease is the potential delay in seeking sight-saving medical treatment. Patients should exercise extreme caution with herbal supplements, as some can interact with immunosuppressive medications or blood thinners often used in the management of Eales disease. Always disclose any supplement use to your retinal specialist.

Next steps

Consult your ophthalmologist before starting any new supplement or lifestyle change.
    Monitor for warning signs of vision changes, such as floaters or blurred vision, which require immediate medical evaluation.
    Join the Eales disease community at DiseaseMaps.org to connect with others sharing their experiences.
    Maintain a strict adherence to prescribed anti-TB medications if your physician has identified a tubercular association.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; always consult with your healthcare team regarding your specific condition.

References

National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD)
    Orphanet: Rare disease database and clinical information
    PubMed: Peer-reviewed literature on retinal vasculitis and inflammatory ocular conditions
    American Academy of Ophthalmology (AAO) guidelines on peripheral retinal disease

Question 7

Living with Eales Disease. How to live with Eales Disease?

Accepted Answer

Living with Eales disease requires navigating the uncertainty of episodic retinal inflammation and potential vision loss, which can be emotionally overwhelming. By integrating proactive medical management with intentional psychological self-care and strong peer support, patients can maintain a high quality of life and emotional resilience despite the challenges of Eales disease.

What is the emotional impact of Eales disease?
The unpredictable nature of Eales disease, which primarily affects young, healthy adults, can lead to significant anxiety regarding vision stability. Many patients report feelings of isolation or frustration when navigating the diagnostic process. Acknowledging that these feelings are a normal response to a chronic, rare condition is the first step toward reclaiming your sense of agency and emotional well-being.

How can I cope with the challenges of Eales disease?
Practical coping strategies for Eales disease focus on balancing medical adherence with mental health preservation. Building a routine helps manage the stress of frequent ophthalmological monitoring. Consider these strategies to bolster your resilience:

Prioritize vision hygiene: Follow your treatment plan strictly to minimize the impact of Eales disease flares.
    Practice radical acceptance: Focus your energy on what you can control, such as your environment and stress management, rather than the disease progression itself.
    Engage in mindfulness: Techniques like guided imagery or meditation can help reduce the physiological arousal associated with medical anxiety.

Why is community support essential?
Connecting with others is vital when navigating a rare condition. At DiseaseMaps.org, 23 people with Eales disease have shared their experiences, creating a unique space for peer support. Sharing your story with those who truly understand the nuances of Eales disease can transform feelings of isolation into a sense of belonging and collective strength.

When should I seek professional mental health support?
If you find that fear of vision loss or the stress of managing Eales disease begins to interfere with your sleep, work, or relationships, it is time to consult a therapist. A clinical psychologist specializing in chronic illness can provide cognitive-behavioral tools to manage the specific anxieties that arise when living with a rare, sight-threatening condition.

Next steps

Join the Eales disease community at DiseaseMaps.org to connect with others who share your journey.
    Consult with a retina specialist regarding both your physical treatment plan and potential low-vision resources.
    Schedule an introductory session with a therapist experienced in chronic health conditions.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

Orphanet: Portal for rare diseases and orphan drugs (Orpha.net).
    NIH Genetic and Rare Diseases Information Center (GARD).
    PubMed: Clinical literature on the idiopathic nature and management of Eales disease.

Question 8

Eales Disease diet. Is there a diet which improves the quality of life of people with Eales Disease?

Accepted Answer

There is currently no medically validated "Eales Disease diet" that can cure or directly reverse the retinal periphlebitis characteristic of Eales Disease. While dietary modifications cannot replace standard ophthalmological treatments like laser photocoagulation or corticosteroids, maintaining an anti-inflammatory, nutrient-dense diet may support general vascular health and overall well-being for those living with Eales Disease.

Is there a specific diet for Eales Disease?
No specific diet has been proven to alter the clinical course of Eales Disease. Because Eales Disease is an idiopathic inflammatory condition—often linked to an immune response against retinal antigens—the focus of nutritional support is on reducing systemic inflammation. Most clinical experts suggest that a heart-healthy, Mediterranean-style diet is the most appropriate approach for managing the systemic health of patients with Eales Disease.

What foods and nutrients support vascular health?
Since Eales Disease involves peripheral retinal vasculitis, foods that promote healthy blood vessel function are beneficial. These include:

Omega-3 Fatty Acids: Found in salmon, walnuts, and flaxseeds; these may help modulate the systemic inflammatory response.
    Antioxidant-rich produce: Leafy greens, berries, and colorful vegetables provide vitamins C and E, which support endothelial health.
    Hydration: Maintaining adequate water intake is essential for general circulation and ocular health.

Are there foods to avoid or supplements to consider?
While no specific food triggers have been identified for Eales Disease, it is generally recommended to limit highly processed, pro-inflammatory foods, such as excessive refined sugars and trans fats, which can negatively impact vascular integrity. Regarding supplements, there is limited clinical evidence; however, some practitioners may discuss Vitamin D or Omega-3 supplementation based on an individual's blood work. Always consult your ophthalmologist or a clinical nutritionist before adding supplements, especially if you are taking systemic corticosteroids for Eales Disease, as interactions can occur.

How does nutrition interact with medical treatments?
Patients with Eales Disease often require long-term corticosteroid therapy. Steroids can affect bone density and blood glucose levels. Therefore, a diet high in calcium and Vitamin D, along with consistent monitoring of glucose intake, is often recommended to mitigate the side effects of Eales Disease treatment protocols.

Next steps

Consult your ophthalmologist or a registered dietitian before making significant changes to your diet.
    Join the DiseaseMaps.org community to connect with 23 other people sharing their experiences with Eales Disease.
    Keep a food and symptom diary to identify if specific dietary patterns correlate with your flare-ups.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

NIH Genetic and Rare Diseases Information Center (GARD) - Eales Disease overview.
    Orphanet: Portal for rare diseases and orphan drugs.
    PubMed: Current clinical research on the etiology and management of idiopathic retinal vasculitis.

Question 9

What is the history of Eales Disease?

Accepted Answer

Eales disease is an idiopathic inflammatory venous occlusion of the retina that was first described by Henry Eales in 1880, initially characterized as retinal hemorrhages associated with constipation and epistaxis in young men. Since its discovery, medical understanding has evolved from viewing Eales disease as a systemic vascular disorder to a complex, likely immune-mediated condition linked to latent tuberculosis infection.

Who first discovered Eales disease?
The condition was first identified by Henry Eales, a British ophthalmologist, who presented his findings to the Ophthalmological Society of the United Kingdom in 1880. He observed a specific pattern of recurring retinal hemorrhages in young, otherwise healthy men. While Eales initially hypothesized that the condition was linked to vasomotor disturbances, the medical community eventually moved away from his early theories as diagnostic technology advanced.

How has our understanding of Eales disease evolved?
For decades, Eales disease was considered a diagnosis of exclusion. A major turning point in the history of the disease was the identification of a strong association between Eales disease and hypersensitivity to tuberculoprotein, particularly in regions like India. While the exact etiology remains debated, modern research suggests that Eales disease involves an inflammatory process where the body’s immune system reacts to mycobacterial antigens, leading to peripheral retinal periphlebitis and subsequent neovascularization.

What are the major historical milestones in treatment?
Treatment for Eales disease has shifted from observation and systemic steroids to targeted surgical and laser interventions. Key historical milestones include:

Early 20th Century: Reliance on systemic corticosteroids to manage inflammation.
    1970s-1980s: The introduction of photocoagulation, which revolutionized the management of retinal neovascularization.
    Modern Era: The use of anti-VEGF (vascular endothelial growth factor) agents to treat macular edema and prevent vision loss.
    Surgical Advances: Pars plana vitrectomy becoming the gold standard for treating non-clearing vitreous hemorrhages caused by Eales disease.

How has patient advocacy changed?
Historically, patients with Eales disease often felt isolated due to the rarity of the condition. Today, platforms like DiseaseMaps.org connect the 23 community members currently registered, allowing for the sharing of lived experiences and navigation of complex treatment paths. This collective knowledge helps demystify the condition and supports those facing the uncertainty of vision-threatening symptoms.

Next steps

Consult a retina specialist or ophthalmologist experienced in inflammatory eye diseases.
    Undergo testing for latent tuberculosis, as this is a clinically significant factor in many cases.
    Join the DiseaseMaps.org community to connect with others who have been diagnosed with Eales disease.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician.

References

NIH Genetic and Rare Diseases Information Center (GARD)
    Orphanet: Portal for rare diseases and orphan drugs
    PubMed: Clinical reviews on the pathogenesis of retinal periphlebitis
    American Academy of Ophthalmology: Clinical guidelines for peripheral retinal vascular diseases

Question 10

Is it advisable to do exercise when affected by Eales Disease? Which activities would you suggest and how intense should they be?

Accepted Answer

For individuals with Eales Disease, moderate exercise is generally safe and encouraged, provided there is no active intraocular hemorrhage or retinal detachment. Maintaining a healthy lifestyle helps manage systemic inflammation and stress, though patients must prioritize activities that avoid high-impact movements or sudden increases in intraocular pressure.

Is exercise safe for patients with Eales Disease?
Yes, exercise is beneficial for those living with Eales Disease. While the condition primarily affects the peripheral retina, regular physical activity supports cardiovascular health and mental well-being, which are vital when navigating a chronic illness. Currently, 23 members of the DiseaseMaps.org community living with Eales Disease utilize movement to manage stress and maintain physical function. Always consult your ophthalmologist to ensure your retina is stable before beginning a new routine.

What types of exercise are recommended for Eales Disease?
Focus on low-impact, steady-state activities that keep your heart rate consistent without causing significant spikes in blood pressure. Consider the following activities:

Walking or light hiking: Excellent for cardiovascular health and mood regulation.
    Swimming: Provides a full-body workout with minimal joint impact.
    Yoga or Pilates: Focuses on flexibility and breathwork, provided you avoid inverted poses (head-down positions) that increase pressure in the eyes.
    Light strength training: Use lighter weights with higher repetitions to avoid the intense straining associated with heavy lifting.

Which activities should be avoided with Eales Disease?
Activities that involve high-impact jolting, heavy straining (Valsalva maneuver), or high-risk contact sports should be avoided, as these can potentially exacerbate ocular complications in Eales Disease. Specifically, avoid heavy weightlifting, boxing, or contact sports where head trauma is possible. On "difficult days" characterized by eye fatigue or blurred vision, employ pacing strategies such as shorter 10-minute bouts of movement rather than one long session.

How can I start an exercise program safely?
Begin by obtaining medical clearance from your retina specialist. Start with a 15-minute low-intensity routine and increase your duration by no more than 10% per week. If you experience new floaters or sudden vision changes during exercise, stop immediately and contact your physician. Engaging a physical therapist can help tailor a program that accounts for the unique vascular nature of Eales Disease.

Next steps

Schedule a comprehensive eye exam to clear you for physical activity.
    Connect with the 23 community members at DiseaseMaps.org to share experiences with Eales Disease management.
    Monitor your blood pressure and eye health regularly while increasing activity levels.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment for Eales Disease.

References

NIH Genetic and Rare Diseases Information Center (GARD) - Eales Disease overview.
    Orphanet: Portal for rare diseases and orphan drugs.
    PubMed: Clinical studies on the management of retinal vasculitis and Eales Disease.
    DiseaseMaps.org: Community insights and patient-reported data.

Question 11

How is Eales Disease diagnosed?

Accepted Answer

TL;DR: Eales disease is primarily a diagnosis of exclusion made by an ophthalmologist through a comprehensive dilated eye examination and retinal imaging. Because Eales disease lacks a single definitive biomarker, clinicians must rule out other inflammatory or vascular retinal conditions before confirming the diagnosis.

How is Eales disease diagnosed?
The diagnostic process for Eales disease is often a journey of elimination. Because there is no single genetic test or blood marker, the diagnosis relies on the clinical assessment of characteristic retinal changes. Ophthalmologists typically follow a systematic approach to differentiate Eales disease from other conditions that cause peripheral retinal periphlebitis and neovascularization.

What tests are used to identify Eales disease?
To evaluate Eales disease, specialists utilize specialized imaging and laboratory screenings to rule out systemic infections or autoimmune disorders. Key diagnostic tools include:

Fundus Fluorescein Angiography (FFA): The gold standard for visualizing peripheral vascular leakage and non-perfusion characteristic of Eales disease.
    Optical Coherence Tomography (OCT): Used to monitor for macular edema or tractional changes.
    Systemic Screening: Blood tests to exclude tuberculosis (Mantoux test or IGRA), sarcoidosis (ACE levels), and syphilis, which can mimic the presentation of Eales disease.
    Clinical Examination: A thorough dilated slit-lamp examination to observe peripheral retinal periphlebitis.

Which specialists are involved in the diagnostic journey?
Patients often experience a "diagnostic odyssey" because Eales disease is rare and presents with non-specific early symptoms. An ophthalmologist, specifically a retina specialist or a uveitis expert, is the primary clinician responsible for the diagnosis. If you feel your symptoms are being overlooked, it is vital to request a referral to a tertiary eye care center where physicians have experience with rare inflammatory retinal diseases.

What conditions are in the differential diagnosis?
Because Eales disease shares features with other vascular eye conditions, physicians must distinguish it from:

Diabetic retinopathy
    Sickle cell retinopathy
    Ocular sarcoidosis
    Retinal vasculitis secondary to infections like tuberculosis

Next steps

Consult a retina specialist or uveitis expert for a definitive evaluation.
    Request a copy of your fundus imaging and angiography reports to keep in your personal health file.
    Join the 23 members of the DiseaseMaps.org community who are navigating similar experiences with Eales disease to share resources and support.

Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment.

References

NIH Genetic and Rare Diseases Information Center (GARD)
    Orphanet: Portal for rare diseases and orphan drugs
    PubMed: Current clinical literature on idiopathic retinal vasculitis

Question 12

Which are the symptoms of Eales Disease?

Accepted Answer

Eales Disease is a rare, idiopathic inflammatory retinal vasculopathy that primarily causes peripheral retinal periphlebitis, leading to recurrent vitreous hemorrhages and vision loss. Common symptoms include the sudden onset of "floaters," blurred vision, and dark spots in the visual field, typically affecting young, otherwise healthy adults.

What are the primary symptoms of Eales Disease?
The clinical presentation of Eales Disease is typically bilateral, though it may be asymmetric. The condition often progresses through three stages: inflammation, ischemia, and neovascularization. Patients frequently report the following clinical manifestations:

Sudden onset of floaters: Often described as "cobwebs" or dark spots caused by blood leaking into the vitreous humor.
Blurred or decreased vision: Resulting from vitreous hemorrhage or macular edema.
Peripheral vision loss: Caused by progressive retinal ischemia and peripheral vascular occlusion.
Photopsia: Flashes of light that may precede a significant hemorrhage.

How do symptoms progress in Eales Disease?
Eales Disease symptoms often follow a cyclical pattern of quiet periods punctuated by acute episodes of vitreous hemorrhage. In the early stages, patients may be asymptomatic while peripheral periphlebitis develops. As the condition advances, venous sheathing and capillary non-perfusion become more pronounced. Over time, the growth of abnormal new blood vessels (neovascularization) significantly increases the risk of severe, vision-threatening complications like tractional retinal detachment.

Which symptoms impact daily quality of life?
The most debilitating aspect of Eales Disease is the unpredictable nature of vitreous hemorrhages, which can cause sudden, dramatic drops in visual acuity. This volatility often leads to anxiety and limitations in driving, reading, and performing professional duties. Among the 23 community members on DiseaseMaps.org, many report that the emotional toll of managing recurrent flare-ups is as challenging as the physical vision changes.

When should I seek immediate medical attention?
If you have been diagnosed with or suspect Eales Disease, seek an urgent evaluation by a retina specialist if you experience a sudden increase in floaters, a "curtain" falling over your vision, or a rapid, painless decline in visual acuity. These can be signs of a new vitreous hemorrhage or an impending retinal detachment.

Next steps

Schedule a comprehensive dilated fundus examination with a vitreoretinal specialist.
Monitor your vision daily using an Amsler grid to detect subtle changes.
Connect with the 23 members of the Eales Disease community on DiseaseMaps.org to share experiences.
Discuss potential treatment options, such as laser photocoagulation or anti-VEGF injections, with your ophthalmologist.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

National Institutes of Health (NIH) GARD: Genetic and Rare Diseases Information Center.
Orphanet: Portal for rare diseases and orphan drugs.
PubMed: Clinical reviews on idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) and Eales Disease.
American Academy of Ophthalmology (AAO) EyeWiki: Peripheral Retinal Vasculitis.

Question 13

Can people with Eales Disease work? What kind of work can they perform?

Accepted Answer

Most individuals diagnosed with Eales disease can maintain productive careers, as the condition's impact on employability depends primarily on the severity of retinal involvement and the success of vision-stabilizing treatments. While active inflammation or vitreous hemorrhage may require temporary leave, proactive management often allows patients to continue working effectively in a wide range of professional environments.

How does Eales disease affect workplace performance?
Eales disease is an idiopathic peripheral retinal vasculitis that typically affects healthy young adults. The primary challenge in the workplace is fluctuating vision due to recurrent vitreous hemorrhages or macular edema. Because Eales disease does not typically affect cognitive function, most individuals remain fully capable of performing complex, high-level professional tasks, provided their ocular health is monitored by a retina specialist.

What types of work are suitable for those with Eales disease?
Career suitability for those with Eales disease is highly individualized. Many members of the DiseaseMaps community—where 23 people have shared their experiences—work in fields ranging from technology and education to administration. Roles that allow for flexible scheduling are often ideal, as they accommodate the need for frequent ophthalmology appointments or periods of rest during flare-ups of Eales disease.

What workplace accommodations help manage Eales disease?
Proactive communication with employers can secure adjustments that support your ocular health. Effective accommodations often include:

Ergonomic adjustments: Using high-contrast monitors, screen readers, or adjustable lighting to reduce eye strain.
    Flexible scheduling: Allowing for intermittent leave or remote work days during active phases of Eales disease.
    Task modification: Reducing prolonged near-vision work during periods of visual instability.

How can I discuss Eales disease with my employer?
When discussing Eales disease, focus on your functional capabilities rather than just the diagnosis. Provide documentation from your ophthalmologist outlining the nature of the condition and the necessity of periodic monitoring. In many jurisdictions, laws such as the Americans with Disabilities Act (ADA) or the Equality Act protect your right to "reasonable accommodations" to ensure you can perform your essential job functions.

Next steps

Consult with a retina specialist to create a long-term "work-safe" vision management plan.
    Connect with the 23 members on DiseaseMaps.org to learn how they navigate workplace challenges.
    Speak with your HR department early about your rights to workplace accommodations.

Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment.

References

NIH Genetic and Rare Diseases Information Center (GARD): Eales Disease Overview.
    Orphanet: Rare eye disease database and clinical guidelines.
    PubMed: Clinical studies on the visual prognosis and management of retinal vasculitis.
    DiseaseMaps.org: Community insights and patient-reported outcomes for rare conditions.

Question 14

How do I know if I have Eales Disease?

Accepted Answer

TL;DR: Eales disease is a rare inflammatory eye condition characterized by peripheral retinal vasculitis, recurrent vitreous hemorrhages, and neovascularization. If you experience sudden vision changes or floaters, consult an ophthalmologist immediately, as early diagnosis is crucial to prevent permanent vision loss.

What are the early signs of Eales disease?
The hallmark of Eales disease is the sudden onset of painless vision impairment. Patients often report "floaters" or "cobwebs" in their field of vision, which occur when small blood vessels in the retina become inflamed and bleed into the vitreous humor. Because Eales disease typically affects young to middle-aged adults (often between 20 and 40 years old), any unexplained visual disturbance in this demographic should be taken seriously.

How is Eales disease diagnosed?
Diagnosis is usually made by a retina specialist through a comprehensive dilated eye examination. Because Eales disease is a diagnosis of exclusion—meaning other causes of retinal inflammation like diabetes, sarcoidosis, or tuberculosis must be ruled out—your doctor will likely order a specific suite of tests:

Fundus Fluorescein Angiography (FFA): To visualize blood flow and identify areas of retinal non-perfusion or leakage.
    Systemic Workup: Blood tests to rule out inflammatory, infectious (especially tuberculosis), and autoimmune conditions.
    Optical Coherence Tomography (OCT): To assess the health of the retinal layers and check for macular edema.

When should I seek urgent medical care?
If you experience a sudden "curtain" coming over your vision, a dramatic increase in dark floaters, or a significant drop in visual acuity, treat this as a medical emergency. These symptoms in the context of Eales disease may indicate a severe vitreous hemorrhage or retinal detachment. Do not wait for a routine appointment; visit an emergency eye clinic or a retina specialist immediately.

How can I advocate for my eye health?
If you suspect you have Eales disease but feel unheard, request a referral to a uveitis specialist or a retina specialist. Bring a log of your symptoms, including when they occur and whether they affect one or both eyes. You may also join the 23 members of the Eales disease community at DiseaseMaps.org to share experiences and find guidance on navigating the diagnostic journey.

Next steps

Schedule an urgent dilated eye exam with a board-certified ophthalmologist.
    Ask your physician specifically about "peripheral retinal vasculitis" and "idiopathic retinal periphlebitis."
    Keep a symptom diary to track the frequency and severity of your visual disturbances.
    Consult the DiseaseMaps.org community to connect with others who have been diagnosed with Eales disease.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

NIH Genetic and Rare Diseases Information Center (GARD)
    Orphanet: Portal for rare diseases and orphan drugs
    PubMed: Clinical reviews on idiopathic retinal vasculitis
    American Academy of Ophthalmology (AAO) EyeWiki

Question 15

What is the prevalence of Eales Disease?

Accepted Answer

Eales disease is a rare idiopathic inflammatory venous occlusion of the retina, with an estimated prevalence that remains difficult to quantify globally due to its localized clinical concentration. While it is not considered ultra-rare in specific regions, the true global prevalence of Eales disease is unknown, as many cases are likely underdiagnosed or misclassified as other retinal vasculitides.

What is the demographic profile of Eales disease?
Eales disease primarily affects young to middle-aged adults, typically between the ages of 20 and 40. While pediatric cases are documented, they are less common. Clinical studies consistently show a significant gender disparity, with Eales disease occurring predominantly in males, often at a ratio of approximately 9:1 compared to females, though the exact biological mechanism for this skew remains under investigation.

Are there geographic or ethnic variations in Eales disease?
Historically, Eales disease has been most frequently reported in the Indian subcontinent, though it has been identified in populations worldwide. Because it is often associated with a history of tuberculosis exposure, researchers suggest that geographic variations in Eales disease may mirror the regional prevalence of latent or active tuberculosis, acting as a hypersensitivity response rather than a direct infection of the ocular tissue.

Why is accurate prevalence data for Eales disease challenging?
Determining the exact number of people living with Eales disease is difficult for several reasons:

Underdiagnosis: Peripheral retinal changes in early-stage Eales disease can be asymptomatic and go unnoticed until significant vision loss occurs.
    Diagnostic Overlap: The condition is often misdiagnosed as other forms of uveitis or retinal vasculitis.
    Reporting Bias: Much of the existing literature on Eales disease originates from tertiary referral centers in specific countries, which may not accurately reflect global incidence.

At DiseaseMaps.org, we have seen 23 individuals join our community to share their experiences with Eales disease, providing a vital real-world perspective that complements clinical data by highlighting the patient journey and the diagnostic hurdles faced by those living with this condition.

Next steps

Consult a retina specialist or ophthalmologist if you experience sudden floaters or blurred vision.
    Maintain regular follow-ups to monitor retinal vascular changes.
    Join the DiseaseMaps.org community to connect with others currently managing Eales disease.
    Discuss with your physician if screening for systemic inflammatory or infectious conditions is appropriate for your case.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

NIH Genetic and Rare Diseases Information Center (GARD): Eales disease overview.
    Orphanet: Rare eye diseases database.
    PubMed/NCBI: Epidemiological studies on idiopathic retinal vasculitis and Eales disease.

Question 16

What are the best treatments for Eales Disease?

Accepted Answer

Treatment for Eales disease focuses on managing retinal inflammation and preventing vision-threatening complications like vitreous hemorrhage or neovascularization. Because Eales disease is an idiopathic inflammatory condition, management is highly personalized, often involving corticosteroids to control inflammation and laser photocoagulation to address abnormal blood vessel growth.

How is Eales disease medically managed?
There is no single "cure" for Eales disease, so clinicians aim to stabilize the retina. First-line therapy typically involves oral or local corticosteroids to reduce vasculitis. If the disease progresses to proliferative stages, ophthalmologists use scatter laser photocoagulation to destroy ischemic retinal areas, preventing further neovascularization. In cases where the condition has caused significant bleeding, surgical intervention becomes necessary.

What surgical interventions are used for Eales disease?
When medication alone cannot manage the complications of Eales disease, surgery is required to restore vision. Common procedures include:

Pars Plana Vitrectomy: A surgical procedure to remove the vitreous gel, often performed to clear persistent vitreous hemorrhage.
    Membrane Peeling: Removal of fibrovascular membranes that may cause retinal traction or detachment.
    Endolaser photocoagulation: Performed during surgery to treat peripheral retinal ischemia.

Which specialists should be on my care team?
Managing Eales disease requires a multidisciplinary approach to address both the eye condition and potential underlying systemic triggers. Your care team should include:

Retina Specialist: An ophthalmologist specializing in retinal diseases to manage inflammation and surgery.
    Internist or Rheumatologist: To investigate potential associations with systemic inflammatory or autoimmune conditions.
    Infectious Disease Specialist: Often consulted to rule out latent tuberculosis, which has been historically linked to Eales disease in some populations.

How does treatment effectiveness vary?
The prognosis for Eales disease varies significantly based on the stage of presentation. While many patients experience stable vision with early laser intervention, others may face recurrent hemorrhages. Because 23 members of the DiseaseMaps community have shared their experiences, we know that patient journeys are unique; some respond rapidly to steroids, while others require long-term monitoring for complications like macular edema.

Next steps

Schedule regular dilated eye examinations with a vitreoretinal specialist.
    Discuss with your doctor if testing for latent tuberculosis is appropriate based on your clinical presentation.
    Connect with others at DiseaseMaps.org to share experiences and coping strategies for living with Eales disease.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with your healthcare provider for personalized treatment plans.

References

National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD)
    Orphanet: Portal for rare diseases and orphan drugs
    PubMed: Clinical reviews on the management of idiopathic retinal vasculitis

Question 17

Eales Disease and depression

Accepted Answer

Eales Disease is an idiopathic inflammatory retinal vasculopathy that can lead to significant vision loss, frequently resulting in secondary depression and anxiety due to the fear of permanent blindness. While there is no direct biochemical link between Eales Disease and mood disorders, the psychological burden of managing a chronic, sight-threatening condition is a well-documented challenge for the 23 members of the DiseaseMaps community living with this diagnosis.

Why does Eales Disease impact mental health?
The emotional toll of Eales Disease is largely driven by the unpredictability of flare-ups and the potential for sudden vision impairment. Patients often experience "medical trauma" related to recurring ocular surgeries and laser treatments. The uncertainty regarding whether vision will stabilize or deteriorate creates a state of chronic hypervigilance, which can manifest as generalized anxiety or clinical depression.

What are the common emotional challenges for patients?
Living with Eales Disease often requires significant lifestyle adjustments, which can trigger feelings of isolation. Patients commonly report the following psychological stressors:

Fear of the future: Constant worry about potential permanent vision loss.
Loss of autonomy: Difficulty driving, reading, or working during acute episodes.
Social withdrawal: Avoiding activities due to visual fatigue or the visible signs of ocular inflammation.
Treatment burden: Exhaustion from frequent hospital visits and the side effects of systemic steroids often used to treat Eales Disease.

How can patients manage depression and anxiety?
Effective management involves a multidisciplinary approach. Cognitive Behavioral Therapy (CBT) is highly effective for re-framing thoughts related to chronic illness, while Acceptance and Commitment Therapy (ACT) can help patients focus on living a meaningful life despite visual limitations. Antidepressant medications may also be prescribed by a psychiatrist to address the neurochemical impacts of chronic stress associated with Eales Disease.

When should you seek professional help?
If you notice persistent feelings of hopelessness, changes in sleep or appetite, or a loss of interest in activities you once enjoyed, please consult a mental health professional. If you are experiencing suicidal thoughts, please call 988 (in the US) or contact your local emergency services immediately.

Next steps

Consult with your ophthalmologist about the psychological impact of your Eales Disease treatment plan.
Connect with the 23 members of the DiseaseMaps Eales Disease community for peer support.
Inquire about low-vision rehabilitation services to regain independence.
Seek a therapist specializing in chronic health conditions or medical trauma.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

NIH Genetic and Rare Diseases Information Center (GARD)
Orphanet: Rare disease database
PubMed: Clinical studies on the psychosocial impact of retinal vasculitis
DiseaseMaps.org community data

Question 18

Which are the causes of Eales Disease?

Accepted Answer

TL;DR: Eales disease is an idiopathic inflammatory condition characterized by peripheral retinal vasculitis, meaning the exact cause remains unknown. While researchers have not identified a single genetic mutation responsible for Eales disease, strong evidence points toward a complex interplay between autoimmune responses, potential infectious triggers like tuberculosis, and inflammatory processes.

What is the underlying cause of Eales disease?
The exact etiology of Eales disease remains a subject of ongoing medical debate. Because we call it "idiopathic," we acknowledge that the primary trigger is not fully understood. However, Eales disease is widely considered an immune-mediated disorder. Think of the immune system as a security team that has mistakenly identified healthy blood vessels in the retina as "intruders," leading to chronic inflammation and tissue damage.

Are there known environmental or infectious triggers?
Research into Eales disease has frequently identified a historical or latent association with Mycobacterium tuberculosis. Although the bacteria are rarely found directly in the eye, the body’s immune reaction to the infection may trigger the inflammatory cascade seen in Eales disease. Other potential factors currently being investigated include:

Hypersensitivity: An overactive immune response to bacterial proteins.
    Oxidative Stress: An imbalance between free radicals and antioxidants in the ocular tissues.
    Genetic Predisposition: Specific HLA (Human Leukocyte Antigen) types, such as HLA-DR1 and HLA-DR4, have been observed in some patient cohorts, suggesting a genetic susceptibility.

What is the difference between a cause and a risk factor?
In Eales disease, a "cause" would be the direct biological mechanism that initiates the inflammation, which we have yet to isolate. A "risk factor," such as exposure to tuberculosis or specific genetic markers, increases the likelihood that a person might develop the condition but does not guarantee it. Understanding this distinction is vital for researchers at DiseaseMaps.org as we collect data from our 23 community members to better map the patient journey.

How is current research evolving?
Medical researchers are currently utilizing proteomic and genomic studies to look for biomarkers that could definitively identify the cause of Eales disease. By analyzing the blood and vitreous fluid of patients, scientists hope to clarify whether Eales disease is a singular entity or a spectrum of inflammatory responses triggered by various environmental stressors.

Next steps

Consult a retina specialist or ophthalmologist for regular dilated fundus examinations.
    Discuss screening for latent tuberculosis with your primary care physician.
    Join the DiseaseMaps.org community to connect with others sharing their experiences with Eales disease.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

National Institutes of Health (NIH) GARD: Eales disease overview.
    PubMed: "Eales Disease: A Review of the Current Understanding" (PMID: 25624758).
    Orphanet: Rare eye disease database entries.
    Review of Ophthalmology: Clinical updates on retinal vasculitis.

Question 19

Does Eales Disease have a cure?

Accepted Answer

Currently, there is no definitive cure for Eales disease, a rare idiopathic inflammatory retinal vasculopathy. While a permanent cure remains elusive, modern medical interventions are highly effective at managing inflammation and preventing vision-threatening complications, allowing many patients to achieve long-term disease stabilization.

What is the current approach to managing Eales disease?
Because the exact cause of Eales disease remains unknown—though it is strongly associated with hypersensitivity to tuberculoprotein—treatment focuses on symptom management and inflammation control. Current therapies aim to prevent permanent vision loss caused by retinal ischemia and vitreous hemorrhage. Patients often achieve remission through a combination of:

Corticosteroids to reduce acute retinal inflammation.
Laser photocoagulation to manage peripheral retinal non-perfusion.
Pars plana vitrectomy for patients suffering from non-clearing vitreous hemorrhage.
Anti-VEGF injections to address neovascularization and macular edema.

What does the future of research look like for Eales disease?
Research into Eales disease is shifting toward understanding the underlying immunological triggers. Scientists are investigating the role of oxidative stress and inflammatory biomarkers to develop targeted therapies. While gene therapy is not currently a standard treatment for Eales disease, the growing field of precision ophthalmology is exploring how genetic predispositions might influence individual responses to anti-inflammatory treatments.

Are there clinical trials for Eales disease?
Clinical trials specifically for Eales disease are limited due to its rarity. Most active research involves observational studies or retrospective analyses of existing surgical and pharmacological outcomes. To stay informed about potential breakthroughs, patients should monitor the NIH ClinicalTrials.gov database for updates on retinal vasculitis research. As our community of 23 members on DiseaseMaps.org continues to grow, sharing collective experiences helps highlight the urgent need for larger, multi-center studies.

Next steps

Consult a retina specialist or a uveitis expert to establish a personalized management plan.
Monitor vision changes closely and undergo regular dilated eye examinations.
Join the DiseaseMaps.org community to connect with others living with Eales disease and stay updated on emerging patient-led research initiatives.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

NIH Genetic and Rare Diseases (GARD) Information Center
Orphanet: Portal for rare diseases and orphan drugs
PubMed: National Library of Medicine (Review of idiopathic retinal vasculitis)
American Academy of Ophthalmology (EyeWiki)

Question 20

What is Eales Disease

Accepted Answer

Eales Disease is a rare, idiopathic inflammatory condition primarily affecting the peripheral retina, characterized by recurring retinal hemorrhages and vascular inflammation. It typically presents in young adults and can lead to vision loss if the resulting complications, such as retinal detachment or neovascularization, are not managed by a retina specialist.

What is the pathophysiology of Eales Disease?
The exact cause of Eales Disease remains unknown, though it is widely considered an immune-mediated vasculitis. The condition progresses through three distinct clinical stages: inflammation (periphlebitis), ischemia (capillary non-perfusion), and proliferation (neovascularization). Unlike other retinopathies, Eales Disease is uniquely defined by its peripheral location and the absence of systemic vascular diseases like diabetes or hypertension.

Who is typically affected by Eales Disease?
Eales Disease predominantly affects healthy young males, typically between the ages of 20 and 40. While it was historically reported most frequently in the Indian subcontinent, cases have been documented globally. At DiseaseMaps.org, 23 community members are currently navigating their journey with this condition, highlighting the importance of shared experiences in managing this rare diagnosis.

What are the primary clinical features?
Patients with Eales Disease often notice "floaters" or sudden blurred vision caused by vitreous hemorrhage. Key clinical features include:

Peripheral periphlebitis: Inflammation of the retinal veins.
    Retinal ischemia: Areas of the retina lacking adequate blood supply.
    Neovascularization: The growth of fragile new blood vessels that are prone to bleeding.
    Vitreous hemorrhage: Bleeding into the gel-like substance of the eye.

How is Eales Disease differentiated from other conditions?
It is critical to distinguish Eales Disease from other inflammatory retinal conditions like sarcoidosis, Behçet’s disease, and ocular tuberculosis. A diagnosis of Eales Disease is essentially a diagnosis of exclusion, meaning clinicians must perform systemic testing to rule out these other infectious or inflammatory triggers before confirming the diagnosis.

Next steps

Consult a retina specialist for a comprehensive dilated eye exam and fundus fluorescein angiography.
    Discuss potential systemic workups to rule out underlying inflammatory or infectious conditions.
    Join our community of 23 members at DiseaseMaps.org to share experiences and coping strategies.
    Monitor for sudden changes in vision and seek immediate care if new "floaters" or vision loss occur.

Medical disclaimer: This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

NIH Genetic and Rare Diseases Information Center (GARD)
    Orphanet: Portal for rare diseases and orphan drugs
    PubMed: Clinical reviews on idiopathic peripheral retinal vasculitis
    American Academy of Ophthalmology (AAO) EyeWiki

Question 21

Eales Disease prognosis

Accepted Answer

The prognosis for Eales disease is generally favorable, as the condition is often self-limiting; however, long-term visual outcomes depend heavily on early diagnosis and the management of retinal complications. While many patients maintain stable vision with appropriate intervention, Eales disease requires proactive monitoring to prevent permanent sight loss from vitreous hemorrhage or retinal detachment.

What determines the prognosis of Eales disease?
The clinical course of Eales disease is typically characterized by distinct stages: inflammation (periphlebitis), ischemia, and neovascularization. Prognosis is best when the condition is identified during the initial inflammatory phase. In our DiseaseMaps community, where 23 people with Eales disease share their experiences, we see that those who adhere to consistent follow-up schedules report significantly better long-term visual acuity than those who seek care only during acute symptomatic flares.

What are the potential complications of Eales disease?
While Eales disease is usually manageable, persistent vascular changes can lead to sight-threatening complications. Patients must be vigilant for symptoms of these secondary issues, which include:

Vitreous hemorrhage: Sudden vision loss caused by bleeding from fragile new blood vessels.
    Tractional retinal detachment: Fibrous tissue pulling on the retina, requiring surgical intervention.
    Neovascular glaucoma: Increased eye pressure resulting from abnormal vessel growth.
    Macular edema: Fluid accumulation that can blur central vision.

How has the management of Eales disease evolved?
Modern medicine has drastically improved the outlook for Eales disease. In previous decades, treatment options were limited, but today, the use of anti-VEGF injections, targeted laser photocoagulation, and advanced vitrectomy techniques allow ophthalmologists to preserve vision much more effectively. These proactive, minimally invasive treatments have shifted the management of Eales disease from reactive surgery to preventative care, greatly enhancing the quality of life for most patients.

Next steps

Schedule regular dilated eye exams with a retina specialist to monitor vascular health.
    Maintain a symptom log to track potential visual disturbances between appointments.
    Join the Eales disease community on DiseaseMaps.org to connect with others who understand the unique challenges of this condition.
    Discuss with your physician whether systemic screening for associated inflammatory markers is necessary.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

NIH Genetic and Rare Diseases Information Center (GARD): Eales Disease Overview.
    Orphanet: Rare Disease Database (ORPHA:99929).
    PubMed: "Management of Eales Disease: A Review of Current Trends and Outcomes."
    Journal of Ophthalmic Inflammation and Infection: Clinical diagnostic criteria for Eales disease.

Question 22

Eales Disease synonyms

Accepted Answer

Eales disease is an idiopathic peripheral retinal vasculitis that primarily affects young, healthy males, historically known as primary retinal periphlebitis. While the term Eales disease remains the standard in modern clinical practice, you may encounter it in older literature as periphlebitis retinae or angiopathia retinae juvenilis.

What are the historical and alternative names for Eales disease?
Because Eales disease was first described in the late 19th century by Henry Eales, the terminology has evolved as our understanding of its inflammatory nature has grown. Historical synonyms often reflect the anatomical location or the demographic initially associated with the condition. These include primary retinal periphlebitis, retinal periphlebitis, and angiopathia retinae juvenilis. Occasionally, older texts may refer to it simply as recurrent retinal hemorrhage, though this is a symptom rather than a specific diagnostic term.

How is Eales disease classified in medical systems?
Medical nomenclature for Eales disease is standardized to ensure consistent reporting across international databases. In the International Classification of Diseases (ICD), it is categorized under retinal vascular disorders. On platforms like Orphanet, Eales disease is recognized as a rare ophthalmological disorder characterized by idiopathic inflammation of the peripheral retinal vessels. The OMIM database tracks it as a distinct clinical entity, though it is often studied alongside broader vasculitis research.

Why does Eales disease have multiple names?
The variety of names for Eales disease stems from its long history of clinical observation. Before the advent of modern diagnostic imaging like fluorescein angiography, clinicians named the condition based on its primary visual manifestation: bleeding in the eye. As research progressed, the name shifted toward a descriptive, etiologically neutral term that reflects the underlying inflammatory process of the retinal veins.

Key terminology facts for patients

Preferred Term: Eales disease is the universally accepted clinical term.
    Historical Context: "Primary retinal periphlebitis" is the most common synonym found in 20th-century literature.
    Global Recognition: While the name is consistent worldwide, some regional literature may append "idiopathic" to emphasize the unknown cause.
    Community Insight: Our DiseaseMaps.org community of 23 members with Eales disease uses the standard name to facilitate support and knowledge sharing.

Next steps

Consult a retina specialist or ophthalmologist to confirm your diagnosis and review your specific retinal findings.
    Request copies of your fluorescein angiography reports, as these provide the most accurate documentation of Eales disease.
    Join the 23 members of the DiseaseMaps.org community to share experiences and stay updated on research.
    Discuss systemic screening with your physician, as the condition is often a diagnosis of exclusion.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

Orphanet (ORPHA: 66635) – Eales disease.
    NIH Genetic and Rare Diseases Information Center (GARD) – Eales disease.
    PubMed – Clinical updates on the management of idiopathic retinal vasculitis.
    OMIM (Online Mendelian Inheritance in Man) – Database entries on idiopathic retinal periphlebitis.

Question 23

What are the latest advances in Eales Disease?

Accepted Answer

TL;DR: Research into Eales disease is currently shifting toward identifying the underlying autoimmune and inflammatory triggers, with a primary focus on the role of Mycobacterium tuberculosis DNA in ocular tissues. While no single "cure" exists, recent advances in anti-VEGF therapy and refined surgical techniques for vitreoretinal complications are significantly improving visual outcomes for patients with Eales disease.

What are the current research priorities for Eales disease?
Modern research into Eales disease is heavily focused on the inflammatory nature of the condition. Studies are increasingly investigating the presence of Mycobacterium tuberculosis genome in the vitreous fluid, suggesting that Eales disease may be an ocular hypersensitivity reaction to tubercular antigens. Researchers are also exploring systemic biomarkers to better distinguish this idiopathic peripheral retinal vasculitis from other forms of uveitis, aiming to create more precise diagnostic criteria.

Are there new treatments available for Eales disease?
Management of Eales disease has evolved from purely observational or surgical approaches to include targeted medical interventions. Recent developments include:

Anti-VEGF Agents: The use of intravitreal anti-vascular endothelial growth factor injections to manage neovascularization and prevent vitreous hemorrhage.
    Immunomodulatory Therapy: The strategic use of corticosteroids and steroid-sparing agents to control chronic inflammation.
    Advanced Vitrectomy: Micro-incision vitrectomy surgery (MIVS) has improved success rates for clearing non-resolving hemorrhages associated with Eales disease.

How can patients contribute to research?
Because Eales disease is rare, patient participation in clinical registries is vital for advancing medical knowledge. Currently, 23 members within the DiseaseMaps.org community are sharing their experiences, helping researchers understand the lived reality of the condition. You can search for active studies on ClinicalTrials.gov by using the term "idiopathic peripheral retinal vasculitis" or "Eales disease." Always discuss potential trial participation with your ophthalmologist to ensure safety and eligibility.

Next steps

Consult a retina specialist or uveitis expert to discuss if anti-VEGF therapy is appropriate for your specific stage of Eales disease.
    Join our community at DiseaseMaps.org to connect with others and stay updated on emerging patient-led research initiatives.
    Monitor ClinicalTrials.gov regularly for new updates on inflammatory ocular disease research.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified healthcare provider.

References

NIH Genetic and Rare Diseases Information Center (GARD)
    Orphanet: Portal for rare diseases and orphan drugs
    PubMed: National Library of Medicine (search: "Eales disease pathogenesis")
    American Academy of Ophthalmology (AAO) clinical guidelines on retinal vasculitis

Question 24

Is it easy to find a partner and/or maintain relationship when you have Eales Disease?

Accepted Answer

Living with Eales Disease can present unique emotional and practical challenges in romantic relationships, primarily due to the unpredictable nature of retinal hemorrhages and potential vision loss. While Eales Disease does not inherently prevent intimacy, open communication and proactive management of health anxiety are essential for maintaining a strong, supportive partnership.

How does Eales Disease impact intimacy and relationships?
The primary impact of Eales Disease on relationships stems from the stress of recurrent eye inflammation and the risk of sudden visual impairment. Partners may feel overwhelmed by the need to assist with medical appointments or daily tasks during flares. Intimacy can be affected if the patient experiences anxiety regarding physical exertion or the psychological burden of a chronic, idiopathic condition, which can sometimes lead to withdrawal or reduced libido.

How can you communicate about Eales Disease with a partner?
Honest communication is the cornerstone of managing Eales Disease within a relationship. Discussing your symptoms, fears, and the unpredictability of the disease early on helps set realistic expectations. Strategies include:

Sharing educational materials about Eales Disease to help your partner understand the condition's non-infectious, inflammatory nature.
    Clearly expressing your needs during active flare-ups, whether you require physical assistance or emotional space.
    Scheduling regular "check-ins" to discuss how the condition is affecting the partnership, separate from medical logistics.

Is Eales Disease hereditary and how does this affect family planning?
Current medical literature suggests that Eales Disease is likely multifactorial, involving potential genetic predispositions and environmental triggers, rather than following a simple Mendelian inheritance pattern. Because the exact etiology remains elusive, there is no standardized genetic testing for Eales Disease. Couples considering family planning should consult with a genetic counselor to discuss their specific medical history and any concerns regarding potential hereditary risks.

When should couples seek professional support?
If the stress of managing Eales Disease leads to chronic conflict, isolation, or depression, seeking a therapist specializing in chronic illness is highly recommended. Counseling provides a neutral space to navigate the "patient-caregiver" dynamic, ensuring that the relationship remains a partnership rather than a caretaking role.

Next steps

Connect with the 23 members of the Eales Disease community at DiseaseMaps.org to share coping strategies.
    Consult a psychologist who specializes in chronic health conditions to manage medical anxiety.
    Schedule a session with a couples therapist to improve communication patterns.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

National Institutes of Health (NIH) GARD: Eales Disease overview.
    Orphanet: Rare eye disease database and clinical information.
    PubMed: Recent clinical studies on the systemic associations of Eales Disease.
    American Academy of Ophthalmology: Patient resources on retinal vasculitis.

Question 25

Which advice would you give to someone who has just been diagnosed with Eales Disease?

Accepted Answer

TL;DR: Eales disease is a rare, idiopathic inflammatory condition primarily affecting the peripheral retina, characterized by recurrent vitreous hemorrhages. The most critical advice for those newly diagnosed with Eales disease is to establish a long-term partnership with a retina specialist and adhere strictly to regular, scheduled fundus examinations to monitor disease progression.

How do I build an effective care team for Eales disease?
Managing Eales disease requires a coordinated approach. Your primary point of contact should be a vitreoretinal surgeon who understands the specific inflammatory nature of Eales disease. Because the exact etiology remains unknown, your team may also include an internist or rheumatologist to rule out systemic inflammatory conditions that sometimes mimic the symptoms of Eales disease.

What are the most important daily management tips?
Living with Eales disease often involves managing visual fluctuations caused by vitreous hemorrhage. To maintain your quality of life, consider these practical steps:

Prioritize regular follow-ups: Early detection of neovascularization (new, fragile blood vessel growth) is essential.
Monitor visual changes: Keep a journal of any "floaters" or sudden vision blurring, as these are common symptoms of Eales disease progression.
Protect your eyes: Wear high-quality sunglasses when outdoors, as light sensitivity can sometimes accompany retinal inflammation.
Reduce physical strain: During active phases of Eales disease, avoid strenuous heavy lifting that may increase intraocular pressure.

Why should I connect with the Eales disease community?
You are not alone in this journey. Currently, 23 people with Eales disease have joined the DiseaseMaps.org community to share their experiences. Connecting with peers provides invaluable emotional support and practical tips for navigating the uncertainty of Eales disease, helping to reduce the isolation often felt with rare retinal conditions.

Next steps

Schedule a baseline dilated eye examination with a retina specialist.
Join the Eales disease patient community at DiseaseMaps.org to connect with others.
Ask your ophthalmologist about the latest research on anti-VEGF therapies and laser photocoagulation for managing Eales disease.
Consult a low-vision specialist if your daily activities are significantly impacted by visual field loss.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment from your healthcare provider.

References

National Institutes of Health (NIH) - Genetic and Rare Diseases (GARD) Information Center.
Orphanet: Portal for rare diseases and orphan drugs.
PubMed: Current clinical research on the pathogenesis and management of Eales disease.

Help others answering the top 25 questions of Eales Disease

What is the life expectancy of someone with Eales Disease?

1 answer

Celebrities with Eales Disease

1 answer

Is Eales Disease hereditary?

1 answer

Is Eales Disease contagious?

1 answer

ICD10 code of Eales Disease and ICD9 code

1 answer

Is there any natural treatment for Eales Disease?

1 answer

Living with Eales Disease. How to live with Eales Disease?

1 answer

Eales Disease diet. Is there a diet which improves the quality of life of people with Eales Disease?

1 answer

What is the history of Eales Disease?

1 answer

Is it advisable to do exercise when affected by Eales Disease? Which activities would you suggest and how intense should they be?

1 answer

How is Eales Disease diagnosed?

1 answer

Which are the symptoms of Eales Disease?

1 answer

Can people with Eales Disease work? What kind of work can they perform?

1 answer

How do I know if I have Eales Disease?

1 answer

What is the prevalence of Eales Disease?

1 answer

What are the best treatments for Eales Disease?

1 answer

Eales Disease and depression

1 answer

Which are the causes of Eales Disease?

1 answer

Does Eales Disease have a cure?

1 answer

What is Eales Disease

1 answer

Eales Disease prognosis

1 answer

Eales Disease synonyms

1 answer

What are the latest advances in Eales Disease?

1 answer

Is it easy to find a partner and/or maintain relationship when you have Eales Disease?

1 answer

Which advice would you give to someone who has just been diagnosed with Eales Disease?

1 answer